Clinical Features and Risk Factors of HIV-infected Patients with Intracerebral Hemorrhage: a Retrospective Study with Propensity Score Matching Analysis

Overview

Journal Front Cell Infect Microbiol

Date 2025 Jan 22

PMID 39839258

Authors

Qiuhui Huang

Shengri Chen

Hua Huang

Xuhui Deng

Gengyu Cen

Miao Wang

Zhijian Liang

Affiliations

Soon will be listed here.

Abstract

Purpose: To investigate the clinical features and risk factors of the human immunodeficiency virus (HIV)-infected patients with intracerebral hemorrhage (ICH).

Patients And Methods: The patients with HIV-infected without ICH group were matched to the group of HIV-infected ICH patients. Logistic regression analysis using 1:1 propensity score matching (PSM) was performed to investigate the independent risk factors for ICH in HIV-infected patients. The receiver operating characteristic (ROC) curve was configured to calculate the optimal predictors of ICH in HIV-infected patients.

Results: A total of 59 HIV-infected patients with ICH and 180 HIV-infected patients without ICH were included. A cohort of 118 patients was ascertained utilizing PSM. Multivariate binary logistic regression analysis revealed that drug abuse-related HIV-infected, prolonged prothrombin time (PT), and elevated triglyceride (TG) levels were independent risk factors of ICH in HIV-infected patients. The ROC curve demonstrated that the combined predictor, composed of drug abuse-related HIV-infected, prolonged PT, and elevated TG levels, exhibited the highest area under the curve (AUC), with a cut-off point at 0.426, sensitivity of 78%, and specificity of 81.4%.

Conclusion: The present study revealed that a valuable factor combined with drug abuse-related HIV-infected, prolonged PT, and elevated serum TG levels could serve as predictors of ICH in HIV-infected patients.

References

Green R, Kelly K, Gabrielsen T, Levine S, Vanderzant C . Multiple intracerebral hemorrhages after smoking "crack" cocaine. Stroke. 1990; 21(6):957-62. DOI: 10.1161/01.str.21.6.957. View

Pinto A . AIDS and cerebrovascular disease. Stroke. 1996; 27(3):538-43. DOI: 10.1161/01.str.27.3.538. View

Hsue P, Waters D . HIV infection and coronary heart disease: mechanisms and management. Nat Rev Cardiol. 2019; 16(12):745-759. PMC: 8015945. DOI: 10.1038/s41569-019-0219-9. View

Ovbiagele B, Nath A . Increasing incidence of ischemic stroke in patients with HIV infection. Neurology. 2011; 76(5):444-50. PMC: 3034413. DOI: 10.1212/WNL.0b013e31820a0cfc. View

Durand M, Sheehy O, Baril J, LeLorier J, Tremblay C . Risk of spontaneous intracranial hemorrhage in HIV-infected individuals: a population-based cohort study. J Stroke Cerebrovasc Dis. 2012; 22(7):e34-41. DOI: 10.1016/j.jstrokecerebrovasdis.2012.03.014. View

Abdallah A, Chang J, OCarroll C, Musubire A, Chow F, Wilson A . Stroke in Human Immunodeficiency Virus-infected Individuals in Sub-Saharan Africa (SSA): A Systematic Review. J Stroke Cerebrovasc Dis. 2018; 27(7):1828-1836. PMC: 6641537. DOI: 10.1016/j.jstrokecerebrovasdis.2018.02.016. View

Thakur K, Lyons J, Smith B, Shinohara R, Mateen F . Stroke in HIV-infected African Americans: a retrospective cohort study. J Neurovirol. 2015; 22(1):50-5. DOI: 10.1007/s13365-015-0363-x. View

van Swieten J, Koudstaal P, Visser M, Schouten H, van Gijn J . Interobserver agreement for the assessment of handicap in stroke patients. Stroke. 1988; 19(5):604-7. DOI: 10.1161/01.str.19.5.604. View

Tu W, Wang L . China stroke surveillance report 2021. Mil Med Res. 2023; 10(1):33. PMC: 10355019. DOI: 10.1186/s40779-023-00463-x. View

10.

Treadwell S, Robinson T . Cocaine use and stroke. Postgrad Med J. 2007; 83(980):389-94. PMC: 2600058. DOI: 10.1136/pgmj.2006.055970. View

11.

Behrouz R, Topel C, Seifi A, Birnbaum L, Brey R, Misra V . Risk of intracerebral hemorrhage in HIV/AIDS: a systematic review and meta-analysis. J Neurovirol. 2016; 22(5):634-640. DOI: 10.1007/s13365-016-0439-2. View

12.

Raposeiras-Roubin S, Rossello X, Oliva B, Fernandez-Friera L, Mendiguren J, Andres V . Triglycerides and Residual Atherosclerotic Risk. J Am Coll Cardiol. 2021; 77(24):3031-3041. PMC: 8215641. DOI: 10.1016/j.jacc.2021.04.059. View

13.

Jung H, Yang P, Jang E, Yu H, Kim T, Uhm J . Prevalence and Associated Stroke Risk of Human Immunodeficiency Virus-Infected Patients With Atrial Fibrillation　- A Nationwide Cohort Study. Circ J. 2019; 83(12):2547-2554. DOI: 10.1253/circj.CJ-19-0527. View

14.

Sato F, Nakamura Y, Kayaba K, Ishikawa S . TG/HDL-C ratio as a predictor of stroke in the population with healthy BMI: The Jichi Medical School Cohort Study. Nutr Metab Cardiovasc Dis. 2022; 32(8):1872-1879. DOI: 10.1016/j.numecd.2022.05.002. View

15.

Zhang Q, Li X, Wei Z, Ye X, Zhu L, Xie M . Risk factors and clinical characteristics of non-promyelocytic acute myeloid leukemia of intracerebral hemorrhage: A single center study in China. J Clin Neurosci. 2017; 44:203-206. DOI: 10.1016/j.jocn.2017.06.058. View

16.

Waters D, Hsue P . Lipid Abnormalities in Persons Living With HIV Infection. Can J Cardiol. 2019; 35(3):249-259. DOI: 10.1016/j.cjca.2018.11.005. View

17.

Pozzi M, Roccatagliata D, Sterzi R . Drug abuse and intracranial hemorrhage. Neurol Sci. 2008; 29 Suppl 2:S269-70. DOI: 10.1007/s10072-008-0960-z. View

18.

Greenberg S, Ziai W, Cordonnier C, Dowlatshahi D, Francis B, Goldstein J . 2022 Guideline for the Management of Patients With Spontaneous Intracerebral Hemorrhage: A Guideline From the American Heart Association/American Stroke Association. Stroke. 2022; 53(7):e282-e361. DOI: 10.1161/STR.0000000000000407. View

19.

Roquer J, Palomeras E, Knobel H, Pou A . Intracerebral haemorrhage in AIDS. Cerebrovasc Dis. 1998; 8(4):222-7. DOI: 10.1159/000015855. View

20.

Cole J, Pinto A, Hebel J, Buchholz D, Earley C, Johnson C . Acquired immunodeficiency syndrome and the risk of stroke. Stroke. 2003; 35(1):51-6. DOI: 10.1161/01.STR.0000105393.57853.11. View